The Effect of Empagliflozin on Platelet Function Profiles in Patients with Stable Coronary Artery Disease in Trinidad: The EFFECT Pilot Study

INTRODUCTION: This prospective pharmacodynamic (PD) study aimed to assess the effect of the sodium–glucose cotransporter 2 inhibitor (SGLT2i) empagliflozin on platelet reactivity. METHODS: Patients with stable coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM) (n = 20) who were active...

Descripción completa

Detalles Bibliográficos
Autores principales: Seecheran, Naveen, Ramdeen, Arvinash, Debideen, Niranjan, Ali, Kabeer, Grimaldos, Kathryn, Grimaldos, Gabriella, Karan, Abhinav, Seecheran, Rajeev, Seecheran, Valmiki, Persad, Sangeeta, Abdullah, Harun, Peram, Lakshmipathi, Giddings, Stanley, Motilal, Shastri, Tello-Montoliu, Antonio, Schneider, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126525/
https://www.ncbi.nlm.nih.gov/pubmed/33306161
http://dx.doi.org/10.1007/s40119-020-00208-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126525/
https://www.ncbi.nlm.nih.gov/pubmed/33306161
http://dx.doi.org/10.1007/s40119-020-00208-0

Ejemplares similares